Neoadjuvant J591 Treatment for Prostate Cancer

NCT02693860 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: huJ591
DRUG: 89Zr-J591

Sponsor

Weill Medical College of Cornell University